- Home
- MAGH vs TELA Comparison
MAGH vs TELA Comparison
Compare MAGH & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAGH
- TELA
- Stock Information
- Founded
- MAGH 2012
- TELA 2012
- Country
- MAGH Singapore
- TELA United States
- Employees
- MAGH N/A
- TELA N/A
- Industry
- MAGH Engineering & Construction
- TELA Medical/Dental Instruments
- Sector
- MAGH Industrials
- TELA Health Care
- Exchange
- MAGH Nasdaq
- TELA Nasdaq
- Market Cap
- MAGH 51.8M
- TELA 60.6M
- IPO Year
- MAGH 2025
- TELA 2019
- Fundamental
- Price
- MAGH $1.67
- TELA $1.44
- Analyst Decision
- MAGH
- TELA Buy
- Analyst Count
- MAGH 0
- TELA 3
- Target Price
- MAGH N/A
- TELA $5.33
- AVG Volume (30 Days)
- MAGH 210.5K
- TELA 70.3K
- Earning Date
- MAGH 11-08-2025
- TELA 11-06-2025
- Dividend Yield
- MAGH N/A
- TELA N/A
- EPS Growth
- MAGH N/A
- TELA N/A
- EPS
- MAGH 0.00
- TELA N/A
- Revenue
- MAGH $11,752,129.00
- TELA $75,323,000.00
- Revenue This Year
- MAGH N/A
- TELA $25.72
- Revenue Next Year
- MAGH N/A
- TELA $22.03
- P/E Ratio
- MAGH $1,777.24
- TELA N/A
- Revenue Growth
- MAGH N/A
- TELA 16.34
- 52 Week Low
- MAGH $0.99
- TELA $0.86
- 52 Week High
- MAGH $5.15
- TELA $3.26
- Technical
- Relative Strength Index (RSI)
- MAGH N/A
- TELA 37.40
- Support Level
- MAGH N/A
- TELA $1.45
- Resistance Level
- MAGH N/A
- TELA $1.52
- Average True Range (ATR)
- MAGH 0.00
- TELA 0.06
- MACD
- MAGH 0.00
- TELA 0.00
- Stochastic Oscillator
- MAGH 0.00
- TELA 14.29
About MAGH Magnitude International Ltd Ordinary Shares
Magnitude International Ltd is providing electrical installation services to customers in both the private and public sectors in Singapore. It includes the planning, design, material selection, installation, testing, commissioning and certification of the electrical equipment/systems to be installed. The Group's revenue is derived from Singapore.
About TELA TELA Bio Inc.
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.